Another promising treatment option is based on the demonstration that the estrogen – indoleamine 2,3-dioxygenase-1 (IDO1) – mannose receptor C, type 2 (MRC2) axis participates in the differentiation and function of Tregs and is involved in development of endometriosis (318). This evidence concerns the gene IDO1 and endometriosis.